InnoCare Pharma Ltd. (33C)
Market Closed
11 Aug, 20:00
XFRA 
€
1. 63
+0.04
+2.5157%
€
436.94M Market Cap
- P/E Ratio
- Div Yield
3,000 Volume
0 Eps
€ 1.59
Previous Close Want to track 33C and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCare Pharma Ltd. (33C) Statistics
Valuation metrics
Market Cap 436.94M
Enterprise value -4.95B
Trailing P/E (ttm) 4.08
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -4.9
Enterprise Value/EBITDA 15.92
Overview
Shares outstanding 1.76B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 870
Average volume (90 days) 1.2K
Price summary
52-Week low 1.08
52-Week high 2.2
Beta -
50-Day moving average 1.4
200-Day moving average 1.57
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2024
Profitability
Profit margin 0.86%
Operating margin -0.41%
Operational effectiveness
Return on assets -0.05%
Return on equity -0.07%
Income Statement
Revenue (ttm) 1.01B
Revenue per share (ttm) 0.6
Quarterly revenue growth (yoy) 11.63%
Gross profit (ttm) 871.01M
EBITDA -
Net income to common (ttm) -440.63M
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) 0.35%
Balance Sheet
Total cash (mrq) 6.96B
Total cash per share (mrq) -
Total debt (mrq) 1.23B
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 7.57%
Book value per share (mrq) -
Cash Flow
Cash flow statement -583.36M
Levered free cash flow (LFCF) -440.63M
